EQUITY RESEARCH MEMO

Presymptom Health

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)0/100

Presymptom Health Ltd, a diagnostics company based in Cambridge, UK, has entered Members' Voluntary Liquidation (MVL) effective April 7, 2026. The company has ceased trading, and its affairs are being handled by liquidators Ashley Carlton and Adam Brooks of Moorfields. All enquiries should be directed to the liquidators. The company was founded in 2019 but has not achieved commercial viability or secured significant funding, ultimately leading to its dissolution. There are no ongoing operations or prospects for the company.

Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)